Capsulotomy creation equally safe using the manual or energy-based method

News
Article
Ophthalmology Times EuropeOphthalmology Times Europe November 2023
Volume 19
Issue 09

A study demonstrates corneal endothelial cell density measured postoperatively does not differ whether the capsulotomy was performed using continuous curvilinear capsulorhexis (CCC) or precision pulse capsulotomy (PPC)

A beam of energy strikes an upturned dish or lens. Image credit: ©ckybe – stock.adobe.com

The investigators compared the endothelial cell count after cataract surgery in patients whose capsulotomy was created using CCC or PPC. Image credit: ©ckybe – stock.adobe.com

Corneal endothelial cell density measured postoperatively does not differ in patients who have undergone cataract surgery with phacoemulsification whether the capsulotomy was performed using continuous curvilinear capsulorhexis (CCC) or precision pulse capsulotomy (PPC) (Zepto). This is according to data from a study1 by first author Mark C. Vital, MD, and colleagues.

Endothelial cells play a major role in the hydration and transparency of the cornea. Maintaining their density in the eye is thus of paramount importance. Phacoemulsification performed to remove cataractous lenses has been associated with varying degrees of endothelial cell loss at 1 to 3 months postoperatively with losses reported ranging from 5% to 20%.2-14 The cellular loss is theorised to result from ultrasound energy delivered during phacoemulsification and fluidic turbulence during surgery.7,15,16

The investigators compared the endothelial cell count after cataract surgery in patients whose capsulotomy was created using CCC, a manual procedure to create a capsular tear using capsulorhexis forceps, or PPC, an automated procedure, which applies energy to create a capsulotomy in 4 milliseconds.

The authors explained that PPC is performed using an intraocular device with a tip comprising a small flexible suction cup with an embedded nitinol capsulotomy ring. For PPC capsulotomy creation, the tip is inserted into the eye and suction is applied allowing the suction cup and nitinol ring to fully applanate onto the anterior capsule, the surgeons explained. The PPC control console then utilises a short sequence of 12 micro energy pulses lasting a total of 4 milliseconds applied to the capsulotomy ring to create a cutting force based on the rapid phase transition of water molecules in capsular tissue. Once the capsulotomy is created, the suction cup and nitinol ring are removed from the eye, the authors further stated.

The results showed that the mean percentage of endothelial cell density loss at 1 month postoperatively was 11.5% among the patients randomly assigned to the CCC group and 12.3% in the PPC group. This difference that did not reach statistical significance (P = 0.818). At 3 months, the respective percentages of endothelial cell density loss were 11.7% and 12.4%, which also were nonsignificant (P = 0.815).

The mean percentages of hexagonal cells at 1 month was 54.3% in the CCC group and 54.7% in the PPC group (P = 0.695). At 3 months, the respective percentages were 56.2% and 54.7% (P = 0.278). The coefficient of variations at 1 month was 34.4% in the CCC group and 34.3% in the PPC group (P = 0.927) and at 3 months, the respective percentages were 32.7% and 33.4% (P = 0.864).

The investigators concluded that there were no significant differences in the two study groups in any of the corneal endothelial cell parameters measured. “PPC use during cataract surgery does not result in any increased endothelial cell loss beyond that normally associated with this surgery,” they concluded.

References

1. Vital MC, Jong KY, Trinh CE, Starck T,
Sretavan D. Endothelial cell loss following cataract surgery using continuous curvilinear capsulorhexis or precision pulse capsulotomy. Clin Ophthalmol.2023;17:1701–1708. doi:10.2147/OPTH.S411454
2. Acar BT, Utine CA, Acar S, Ciftci F. Endothelial cell loss after phacoemulsification in eyes with previous penetrating keratoplasty, previous deep anterior lamellar keratoplasty, or no previous surgery. J Cataract Refract Surg. 2011;37(11):2013–2017. doi:10.1016/j.jcrs.2011.05.033
3. Hwang HB, Lyu B, Yim HB, Lee NY. Endothelial cell loss after phacoemulsification according to different anterior chamber depths. J Ophthalmol. 2015;2015:210716. doi:10.1155/2015/210716
4. Fea AM, Consolandi G, Pignata G, et al. A comparison of endothelial cell loss in combined cataract and MIGS (Hydrus) procedure to phacoemulsification alone: 6-month results. J Ophthalmol. 2015;2015:769289. doi:10.1155/2015/769289
5. Choi JY, Han YK. Long-term (>/=10 years) results of corneal endothelial cell loss after cataract surgery. Can J Ophthalmol. 2019;54:438–444. doi:10.1016/j.jcjo.2018.08.005
6. Dewan T, Malik PK, Kumari R. Comparison of effective phacoemulsification time and corneal endothelial cell loss using 2 ultrasound frequencies. J Cataract Refract Surg. 2019;45(9):1285–1293. doi:10.1016/j.jcrs.2019.04.015
7. Teoh LS, Foo SW, Mansurali VN, Ang EL, Noh UK, Bastion MC. Evaluation of corneal endothelial cell loss after uncomplicated phacoemulsification cataract surgery with intracameral phenylephrine. Asia Pac J Ophthalmol. 2017;6:318–325. doi:10.22608/APO.2016206
8. Kim EC, Kim MS. A comparison of endothelial cell loss after phacoemulsification in penetrating keratoplasty patients and normal patients. Cornea. 2010;29:510–515. doi:10.1097/ICO.0b013e3181c11e0e
9. Lass JH, Benetz BA, He J, et al. Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol. 2019;208:211–218. doi:10.1016/j.ajo.2019.07.016
10. Walkow T, Anders N, Klebe S. Endothelial cell loss after phacoemulsification: relation to preoperative and intraoperative parameters. J Cataract Refract Surg. 2000;26:727–732. doi:10.1016/S0886-3350(99)00462-9
11. Mahdy MA, Eid MZ, Mohammed MA, Hafez A, Bhatia J. Relationship between endothelial cell loss and microcoaxial phacoemulsification parameters in noncomplicated cataract surgery. Clin Ophthalmol. 2012;6:503–510. doi:10.2147/OPTH.S29865
12. Reuschel A, Bogatsch H, Barth T,
Wiedemann R. Comparison of endothelial changes and power settings between torsional and longitudinal phacoemulsification. J Cataract Refract Surg.2010;36:1855–1861. doi:10.1016/j.jcrs.2010.06.060
13. Tsuneoka H, Shiba T, Takahashi Y. Ultrasonic phacoemulsification using a 1.4 mm incision: clinical results. J Cataract Refract Surg. 2002;28:81–86. doi:10.1016/S0886-3350(01)01235-4
14. Gogate P, Ambardekar P, Kulkarni S, Deshpande R, Joshi S, Deshpande M. Comparison of endothelial cell loss after cataract surgery: phacoemulsification versus manual small-incision cataract surgery: six-week results of a randomised control trial. J Cataract Refract Surg. 2010;36:247–253. doi:10.1016/j.jcrs.2009.09.023
15.Hayashi K, Hayashi H, Nakao F, Hayashi F. Risk factors for corneal endothelial injury during phacoemulsification. J Cataract Refract Surg. 1996;22(8):1079–1084. doi:10.1016/S0886-3350(96)80121-0
16. Richard J, Hoffart L, Chavane F, Ridings B, Conrath J. Corneal endothelial cell loss after cataract extraction by using ultrasound phacoemulsification versus a fluid-based system. Cornea. 2008;27(1):17–21. doi:10.1097/ICO.0b013e3181583115

Mark C. Vital, MD | E: MVital@HoustonEye.com

Dr Vital is from Houston Eye Associates in Houston, Texas, US. He is a consultant to Centricity Vision Inc. (Zepto).

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.